4307:TSENomura Research Institute,Ltd. Analysis
Data as of 2026-03-13 - not real-time
¥4,305.00
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Nomura Research Institute shows solid fundamentals with a price‑earnings multiple comfortably below the industry average and a modest dividend yield supported by a healthy payout ratio. Low beta suggests limited market‑wide volatility, yet the stock exhibits high recent price volatility and a bearish technical backdrop, as price sits above the short‑term moving average but remains under longer‑term averages. Recent earnings highlight a domestic revenue surge that offsets an overseas industrial IT loss, underscoring a resilient core business. Analyst consensus remains positive, with a majority rating of buy, but the combination of decreasing volume and a bearish trend calls for caution in the near term.
Given the undervalued valuation relative to peers, strong cash generation, and sustainable dividend, the medium‑ to long‑term outlook is favorable. Investors should monitor the overseas segment recovery and volume trends, while the current price still offers upside potential against the fair‑value estimates.
Given the undervalued valuation relative to peers, strong cash generation, and sustainable dividend, the medium‑ to long‑term outlook is favorable. Investors should monitor the overseas segment recovery and volume trends, while the current price still offers upside potential against the fair‑value estimates.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish technical trend with price below longer‑term averages
- Decreasing trading volume indicating weaker short‑term liquidity
- Support level providing downside protection
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Undervalued relative to industry PE and upside potential
- Strong domestic earnings momentum
- Low beta reducing market risk
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Sustainable dividend supported by solid cash flow
- Strategic positioning in IT platform and data centre services
- Robust return on equity and consistent profitability
Key Metrics & Analysis
Financial Health
Revenue Growth7.20%
Profit Margin13.16%
P/E Ratio23.9
ROE22.70%
ROA10.25%
Debt/Equity46.81
P/B Ratio4.9
Op. Cash Flow¥143.4B
Free Cash Flow¥37.1B
Industry P/E33.7
Technical Analysis
TrendBearish
RSI46.9
Support¥3,518.00
Resistance¥4,450.00
MA 20¥4,100.20
MA 50¥4,956.58
MA 200¥5,624.20
MACDBullish
VolumeDecreasing
Fear & Greed Index72.41
Valuation
Fair Value¥983.98
Target Price¥5,933.33
Upside/Downside37.82%
GradeUndervalued
TypeBlend
Dividend Yield1.75%
Risk Assessment
Beta0.33
Volatility81.93%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.